Abiopharma

New Form SC TO-C - RAPT Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001193125-26-016042 Size: 70 KB

(99% Neutral) Tivic Health Systems Inc. (TIVC) Provides Update on treatments for future operations

Director Williams Gregg 🟢 acquired 1.7M shares of Vivani Medical, Inc. (VANI) at $1.26 ($2.0M) Transaction Date: Jan 15, 2026 | Filing ID: 000145

(99% Neutral) Synlogic Inc. (SYBX) Files Form 8-K

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

LaPlume Joseph W 🔴 sold 400 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) at $163.72 Transaction Date: Aug 22, 2025 | Filing ID: 000002

Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering

Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia

(99% Neutral) Oragenics Inc. (OGEN) Files Form 8-K

Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes

(99% Neutral) Virios Therapeutics Inc. (VIRI) Announces Enrollment Update for license Due to Patient Enrollment Issues, Manufacturing Considerations

RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center

Curaleaf Announces Strong Preliminary Unaudited Fourth Quarter 2025 Results

Volition Continues to Extend Access to Nu.Q® Vet Cancer Test

(99% Neutral) Coya Therapeutics Inc (COYA) Announces Clinical Development Update